Skip to content
Indigenous, Medical Health Aged Care

Shaping health policies: More public hearings announced for the parliamentary inquiry into diabetes

Department of the House of Representatives 2 mins read

The Standing Committee on Health, Aged Care and Sport will hold five public hearings this month in Canberra, Brisbane, Yarrabah, Cairns, and Melbourne as part of its inquiry into diabetes.

The Chair of the Committee, Dr Mike Freelander MP, said: ‘As part of this broad inquiry, we are looking at all forms of diabetes including type 1, type 2, gestational diabetes, and other rarer forms such as cystic fibrosis-related diabetes. Over the coming days the Committee will hear from stakeholders including:

  • medical professionals and advocates such as Dr James Muecke AM, ophthalmologist and Australian of the Year in 2020
  • national peak bodies like the Obesity Collective
  • national charities including the Butterfly Foundation; and
  • industry groups, including the National Retail Association.

‘Submitters have raised many proposals to prevent and/or better manage diabetes, such as greater access to subsidised diabetes technology, changes to the Medicare Benefits Schedule, a low carbohydrate diet, and policies to improve access to healthy diets including a sugar tax or strengthened Health Star Rating system. The Committee looks forward to exploring these and other ideas at the upcoming hearings’, commented Dr Freelander.

Dr Freelander further stated: ‘The Committee also looks forward to travelling to Yarrabah, an Aboriginal community outside of Cairns, to hear from the local Aboriginal Community Controlled Health Organisation, Gurriny Yealamucka, about its experiences with diabetes.’

The Deputy Chair of the Committee, Mrs Melissa McIntosh MP, added: ‘The Committee will also hear from individuals with lived experience of type 1, type 2, and gestational diabetes. We anticipate that this will offer a better understanding of the daily realities of living with diabetes, including interactions with the healthcare system.’

‘There have been over 450 submissions to the inquiry showing the extent of interest in addressing this major health issue impacting so many Australians,’ Mrs McIntosh said.

Public hearing - Canberra

Date: Friday, 17 November 2023
Time: 8:45am to 3:50pm (Canberra time)
Location: Committee Room 2R1, Parliament House Canberra

Public hearing - Brisbane

Date: Monday, 20 November 2023
Time: 9:00am to 4:45pm (Brisbane time)
Location: Undumbi Room, Queensland Parliament, Corner of George and Alice Streets, Brisbane

Public hearing - Yarrabah

Date: Tuesday, 21 November 2023
Time: TBC (see inquiry website closer to the date for details)
Location: RTC Building, Yarrabah

Public hearing - Cairns

Date: Wednesday, 22 November 2023
Time: 9:00am to 11:00am (Cairns time)
Location: Michaelmas Cay 1 Function Room, Pullman Reef Hotel Casino, 35-41 Wharf Street, Cairns

Public hearing - Melbourne

Date: Thursday, 23 November 2023
Time: 8:30am to 5:00pm (Melbourne time)
Location: Davui Room, Victorian Parliament, 55 St Andrews Place, East Melbourne

Programs for the hearings will be made available on the inquiry website. A live audio stream of the hearings will also be available on the APH website.

Media inquiries

Dr Mike Freelander MP – Committee Chair
[email protected]
(02) 4620 0293

Mrs Melissa McIntosh MP – Committee Deputy Chair
[email protected]
(02) 4722 0600

For background information

Committee Secretariat
02 6277 4145
[email protected]

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.